- Home
- FKWL vs MRSN Comparison
FKWL vs MRSN Comparison
Compare FKWL & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FKWL
- MRSN
- Stock Information
- Founded
- FKWL 1981
- MRSN 2001
- Country
- FKWL United States
- MRSN United States
- Employees
- FKWL N/A
- MRSN N/A
- Industry
- FKWL Telecommunications Equipment
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- FKWL Utilities
- MRSN Health Care
- Exchange
- FKWL Nasdaq
- MRSN Nasdaq
- Market Cap
- FKWL 47.8M
- MRSN 40.7M
- IPO Year
- FKWL 1996
- MRSN 2017
- Fundamental
- Price
- FKWL $3.96
- MRSN $0.36
- Analyst Decision
- FKWL
- MRSN Strong Buy
- Analyst Count
- FKWL 0
- MRSN 5
- Target Price
- FKWL N/A
- MRSN $5.75
- AVG Volume (30 Days)
- FKWL 31.5K
- MRSN 2.3M
- Earning Date
- FKWL 05-15-2025
- MRSN 08-12-2025
- Dividend Yield
- FKWL N/A
- MRSN N/A
- EPS Growth
- FKWL N/A
- MRSN N/A
- EPS
- FKWL N/A
- MRSN N/A
- Revenue
- FKWL $45,276,495.00
- MRSN $34,006,000.00
- Revenue This Year
- FKWL N/A
- MRSN N/A
- Revenue Next Year
- FKWL N/A
- MRSN $1.30
- P/E Ratio
- FKWL N/A
- MRSN N/A
- Revenue Growth
- FKWL 8.62
- MRSN N/A
- 52 Week Low
- FKWL $3.20
- MRSN $0.26
- 52 Week High
- FKWL $7.45
- MRSN $2.83
- Technical
- Relative Strength Index (RSI)
- FKWL 30.89
- MRSN 46.82
- Support Level
- FKWL $3.92
- MRSN $0.35
- Resistance Level
- FKWL $4.09
- MRSN $0.39
- Average True Range (ATR)
- FKWL 0.09
- MRSN 0.03
- MACD
- FKWL 0.00
- MRSN -0.00
- Stochastic Oscillator
- FKWL 4.76
- MRSN 12.30
About FKWL Franklin Wireless Corp.
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.